High Titer Bio-Based Yield
Combining flux optimization and tolerance enhancement breaks the toxicity-limited yield barrier, achieving commercially relevant Putrescine titer.
Putrescine is a crucial diamine intermediate used primarily for synthesizing high-performance Bio-monomers (Nylon 4,4), a sustainable alternative to petrochemical-based nylons. Its production faces two main challenges: Chemical synthesis is petrochemical-based and toxic; fermentation yield is limited by Putrescine toxicity. The toxicity issue significantly caps the yield attainable through microbial fermentation.
CD Biosynsis employs advanced metabolic and host engineering to overcome these limitations: Metabolic Engineering: Engineer E. coli to overexpress Ornithine Decarboxylase (ODC) and Knockout Putrescine degradation pathways. This redirects cellular carbon flow for high production. Crucially, we enhance tolerance via Toxicity Tolerance: Modify cell membranes or introduce efflux systems. This allows the microbial host to withstand high concentrations of the product, resulting in significantly higher yields and a more economically viable biomanufacturing process, entirely moving away from toxic petrochemical routes.
Get a QuoteThe transition to bio-based Putrescine is hindered by these challenges:
High yield bio-production requires resolving Putrescine toxicity.
CD Biosynsis implements a two-pronged strategy focusing on Metabolic Flux and Host Tolerability:
Ornithine Decarboxylase Overexpression
We overexpress key biosynthetic enzymes e.g. ODC to drive high flux from ornithine to Putrescine and knockout degradation pathways.
Membrane and Efflux System Modification
We engineer the cell membrane lipid composition or introduce efflux pump genes to increase host tolerance to high Putrescine titer.
Biosensor-Guided Pathway Tuning
We utilize Putrescine-responsive biosensors to dynamically control gene expression and fine-tune the rate of synthesis and efflux.
Customized Downstream Integration
We develop integrated fermentation and separation systems e.g. in situ product removal to mitigate toxicity and reduce processing cost.
These strategies result in a high-titer, bio-based, and sustainable Putrescine production platform.
Our Putrescine engineering service offers these core benefits:
High Titer Bio-Based Yield
Combining flux optimization and tolerance enhancement breaks the toxicity-limited yield barrier, achieving commercially relevant Putrescine titer.
Sustainable Nylon Precursor
Production from renewable sugars or low-cost biomass replaces petrochemicals, providing a sustainable monomer for Nylon 4,4.
Improved Host Robustness
Engineered membrane or efflux systems create a more robust microbial host that performs reliably under high product concentrations and industrial conditions.
Simplified Purification
The higher titer achieved in fermentation reduces the volume of broth required for downstream processing, saving time and energy in diamine recovery.
Avoids Toxic Byproducts
The fermentation route replaces harsh chemical synthesis steps, eliminating the generation of toxic intermediates and waste.
We deliver a high-yield, clean, and sustainable Putrescine production system.
Our Putrescine engineering service follows a rigorous metabolic and host engineering workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and product stability attributes.
Explore the potential for a high-yield, bio-based Putrescine supply. CD Biosynsis provides customized strain and process engineering solutions:
Why is Putrescine toxic to microbes like E. coli?
Putrescine is a small positively charged molecule at fermentation pH. High concentrations of this diamine interact strongly with the negatively charged cell membrane e.g. lipopolysaccharides, disrupting its integrity, leading to leakage of intracellular contents, impaired growth, and eventually cell death. Tolerance engineering mitigates this effect.
How does Nylon 4,4 compare to Nylon 6 or Nylon 6,6?
Nylon 4,4, derived from bio-based Putrescine and succinic acid, offers superior properties compared to petroleum-based Nylon 6 and Nylon 6,6. It is fully bio-based and exhibits higher melting temperature, better dimensional stability, and lower water absorption, making it ideal for engineering plastics and textiles.
What is the role of efflux systems in tolerance engineering?
Efflux systems are membrane proteins that actively pump toxic compounds out of the cell. By overexpressing a Putrescine-specific efflux pump, we can continuously export the product into the broth as it is produced, keeping the intracellular concentration below toxic levels and maximizing production titer.
What is the estimated project timeline?
A comprehensive project involving metabolic engineering, efflux system design, and fermentation optimization typically requires 35-45 weeks for final high-titer Putrescine protocol delivery and titer validation.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.